Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) has been assigned a consensus rating of "Buy" from the nine brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, six have assigned a buy…
Continue reading...